S2 E12
Alternative Names: S2E12Latest Information Update: 24 Nov 2020
At a glance
- Originator Institut Pasteur; University of Washington; Vir Biotechnology
- Developer Vir Biotechnology
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Phagocyte stimulants; Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections